Emerging patterns of practice in the implementation and application of sentinel lymph node biopsy in breast cancer patients in the United States

Journal of Surgical Oncology

Volumn 83, Issue 2, 2003, Pages 65-67

  Shoher, Angela ^a   Lucci, Anthony ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER PATIENT; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MEDICAL PRACTICE; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SHORT SURVEY; SURGICAL PATIENT; UNITED STATES;

BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; HEALTH PLAN IMPLEMENTATION; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PHYSICIAN'S PRACTICE PATTERNS; SENTINEL LYMPH NODE BIOPSY; SURGERY; UNITED STATES;

EID: 0038209391     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10250     Document Type: Short Survey

References (18)

1. Burak WE, Hollenbeck ST, Zervos EE, et al.: Sentinel lymph node biopsy results in less postoperateve morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002;183:23-27.
2. Chung M, Steinhoff M, Cady B: Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 2002;184:310.
3. Breast Cancer Facts and Figures 2001-2002. The American Cancer Society. www.cancer.org
4. Schwartz GF: The current treatment of ductal carcinoma in situ. Breast J 2001;7:308-310.
5. Dupont EL, Kuhn MA, McCann C, et al.: The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 2000;180:274-277.
6. Mamounas EP, Fisher B: Preoperative (neoadjuvant) chemotherapy in patients with breast cancer. Semin Oncol 2001;28:389-399.
7. Julian T, Dusi D, Wolmark N: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2002;184:315.
8. Breslin TM, Cohen L, Sahin A, et al.: Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000;18:3480-3486.
9. Nason KS, Anderson BO, Byrd DR, et al.: Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000;89:2187-2194.
10. Simmons RM: Review of sentinel lymph node credentialing: How many cases are enough? J Am Coll Surg 2001;193:206-209.
11. Giuliano AF: See one, do twenty-five, teach one: The implementation of sentinel node dissection in breast cancer. Ann Surg Oncol 1999;6:520-521.
12. Lucci A, Pond RK, Miller C, et al.: National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 2001;192:453-458.
13. The American Society of Breast Surgeons. www.breastsurgeons.org
14. Torrenga H, Rahusen FD, Borgstein PJ, et al.: Sentinel node investigation in breast cancer: Detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Path 2001;54:550-552.
15. Turner RR: Histopathologic assessment of the sentinel lymph node in breast cancer. Ann Surg Oncol 2001;8:56-59.
16. Silverstein MJ, Parker R, Grotting JC, et al.: Ductal carcinoma in situ (DCIS) of the breast: Diagnostic and therapeutic controversies. J Am Coll Surg 2001;192:196-214.
17. Hammond ME, Fitzgibbone PL, Compton CC, et al.: College of American Pathologists Conference XXXV: Solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants. Arch Pathol Lab Med 2000;124:958-965.
18. Litvak DA, Giuliano AE: The results of the department of defense's breast lymphatic mapping study. Ann Surg Oncol 2002;9:528-529.